Mots-clés
SANTEPSY > PATHOLOGIE PSYCHIATRIQUE > NOSOGRAPHIE PSYCHIATRIQUE > TROUBLE DE L'HUMEUR > DEPRESSION > DEPRESSION UNIPOLAIRE > DEPRESSION MAJEURE
DEPRESSION MAJEURESynonyme(s)épisode dépressif majeur |
Documents disponibles dans cette catégorie (18)
Article
Jeanne Leseur ; Charlotte Boiret ; Alix Romier ; Balthazar Bazin ; Louise Basquin ; Emilie Stern ; Guillaume Pineau ; Michel Lejoyeux ; Pierre-Alexis Geoffroy ; Julia Maruani |Currently, there is a major challenge in distinguishing between unipolar and bipolar major depressive episode. A significant body of research has been dedicated to identifying biomarkers that can aid in this differentiation due to its crucial im[...]Article
Objective : The diagnosis of Major Depressive Disorder (MDD) is based on the DSM-V criteria and is established by a clinician. This allows quantifying depression based on clinical criteria. As such, MDD differs from other types of depressions th[...]Article
Julia Maruani ; Charlotte Boiret ; Jeanne Leseur ; Alix Romier ; Balthazar Bazin ; Emilie Stern ; Michel Lejoyeux ; Pierre-Alexis Geoffroy |Previous studies have noted the crucial role of excessive daytime sleepiness (EDS) in the course of depressive illness, and more recently, a few studies documented its strong associations with an increased risk of suicide. While insomnia is asso[...]Article
Olivier Lefebvre ; MELLAS L ; YON V |Objectives : Co-occurring symptoms in depressed people currently in a relationship are sometimes considered to be due to interpersonal variables like dyadic adjustment, or intrapersonal factors such as a lack of dispositional mindfulness. Recent[...]Article
Major Depressive Disorder (MDD) has heterogeneous manifestations, leading to difficulties in predicting the evolution of the disease and in patient's follow-up. We aimed to develop a machine learning algorithm that identifies a biosignature to p[...]Article
Depression is one of the leading causes of morbidity worldwide and increases the risk of suicide. Students are known as a population at risk for depression. This study aimed to evaluate the prevalence of 12 months major depressive episode (MDE) [...]Article
Geoffroy Solelhac ; Mathieu Berger ; Marie-Pierre F. Strippoli ; Nicolea Andrea Marchi ; Aurélie Stephan ; Jean-Marie Petit ; Virginie Bayon ; José Haba-Rubio ; Tiffen Raffray ; Peter Vollenweider ; Pedro Marques-Vidal ; Gerard Waeber ; Damien Leger ; Francesca Siclari ; Pierre-Alexis Geoffroy ; Martin PREISIG ; Raphaël Heinzer |Insomnia and its opposite hypersomnia are part of the diagnostic criteria for major depressive disorder (MDD). However, no study has investigated whether the postulated sleep alterations in clinical subtypes of MDD are reflected in polysomnograp[...]Article
Julia Maruani ; Fanny Molière ; Ophelia Godin ; Antoine Yrondi ; Djamila Bennabi ; Raphaëlle Richieri ; Wissan El-Hage ; Etienne Allauze ; Loic Anguill ; Alexandra BOUVARD ; Vincent Camus ; Jean-Michel Dorey ; Bruno Etain ; Guillaume Fond ; Jean-Baptiste GENTY ; Emmanuel Haffen ; Jérôme Holtzmann ; Mathilde HORN ; François Kazour ; Anne-Sophie Nguon ; Jean Petrucci ; Romain Rey ; Florian Stephan ; Guillaume Vaiva ; Michel Walter ; Michel Lejoyeux ; Marion Leboyer ; Pierre-Michel Llorca ; Philippe Courtet ; Bruno Aouizerate ; Pierre-Alexis Geoffroy |Background: Patients suffering from treatment-resistant depression (TRD) are at risk of suicide. Sleep and circadian rhythm alterations are widely recognized as core symptoms of major depressive disorder and are associated with suicidal ideation[...]Article
Noomane Bouaziz ; Charles LAIDI ; Samuel Bulteau ; Caroline Berjamin ; Fanny Thomas ; Virginie MOULIER ; René Benadhira ; David Szekely ; Emmanuel Poulet ; Filipe Galvao ; Olivier Guillin ; Marie-Carmen Castillo ; Anne Sauvaget ; Marion Plaze ; Dominique Januel ; Jérôme Brunelin ; Maud ROTHARMEL |Background : In 2008, the U.S. FDA approved rTMS as a treatment against medication-resistant depression. However, real-world rTMS outcomes remain understudied. This study investigates how rTMS for depression is delivered in routine clinical prac[...]Livre
Cet ouvrage synthétise les grands concepts de psychopharmacologie (réponse, réponse partielle, rémission, résistance, ultrarésistance, pseudo-résistance) et récapitule le fonctionnement des antidépresseurs et des anxiolytiques avec un focus sur [...]Article
Bénédicte Barbotin ; Nicolas Hoertel ; Mark Olfson ; Carlos Blanco ; Marina Sanchez-Rico ; Michel Lejoyeux ; Frédéric Limosin ; Pierre-Alexis Geoffroy |Objective: Sleep alterations have been suggested as a cause and consequence of psychiatric disorders. In this context, we evaluated the incidence of psychiatric disorders following sleep complaints in adults with major depressive episode (MDE). [...]Article
Anaïs MUNGO ; HEIN M |Le but de cette revue est d’investiguer de manière systématique l’efficacité de l’eskétamine associé à un ISRS ou à un IRSNA dans le cadre d’un trouble dépressif majeur résistant au traitement. Une revue systématique sur l’efficacité de l’eskéta[...]Article
Connaître les modifications pharmacologiques liées au vieillissement dans l’épisode dépressif caractérisé unipolaire du sujet de plus de 65 ans et leur impact sur l’efficacité et le profil de risque des antidépresseurs. Recherche sur Pubmed et C[...]Article
Article
Guillaume Pineau ; E. Jean ; Lucia Romo ; F. Villemain ; D. Poupon ; Philip Gorwood |There are currently no reliable biological markers to identify antidepressant responders in patients suffering from major depressive disorder. In this longitudinal pilot study, we measured skin conductance response (SCR) to assess patients’ emot[...]